Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Edwards SAPIEN XT Transcatheter Heart Valve Therapy for Patients With a Failing Aortic Bioprosthetic Valve

NCT03225001 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03225001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03225001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Edwards SAPIEN XT Transcatheter Heart Valve Therapy for Patients With a Failing Aortic Bioprosthetic Valve
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Completed
Start date
June 11, 2012
Completion date
October 28, 2020
Enrollment
197 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, cardiomyopathy, hypertrophic